Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women

被引:26
|
作者
Rodriguez, EJ [1 ]
Spann, C [1 ]
Jamieson, D [1 ]
Lindsay, M [1 ]
机构
[1] Emory Univ, Sch Med, Dept Gynecol & Obstet, Div Maternal Fetal Med, Atlanta, GA 30303 USA
关键词
cesarean delivery; human immunodeficiency virus; postoperative morbidity;
D O I
10.1067/mob.2001.115179
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The aim of this study was to compare the complication rates associated with cesarean delivery between human immunodeficiency virus-seropositive women with those among a matched group of human immunodeficiency virus-seronegative subjects. STUDY DESIGN: We conducted a case-control study of 86 human immunodeficiency virus-seropositive women undergoing cesarean delivery between the years 1992 and 2000 at a large, urban teaching institution and a control group of 86 human immunodeficiency virus-seronegative women matched for age, race, year of delivery, and delivery indications. Data were analyzed with the chi (2) test and odds ratios. Among human immunodeficiency virus-seropositive women, complications were further stratified according to maternal disease status and use of antiretroviral therapy. RESULTS: Human immunodeficiency virus-seropositive women were significantly more likely than control women to have minor postoperative complications (66.3% vs 41.8%; odds ratio, 2.73; 95% confidence interval, 1.40-6.10), of which febrile morbidity was the most common (62.8% vs 42.7%; P = .003). There was no difference between the groups in the rate of major complications (9.3% vs 3.4%; odds ratio, 2.84; 95% confidence interval, 0.65-14.06). Zidovudine use was associated with a decrease in the maternal morbidity rate (odds ratio, 0.31; 95% confidence interval, 0.07-1.03). CONCLUSION: Postoperative morbidity among human immunodeficiency virus-seropositive women undergoing cesarean delivery was not different from that in a matched control population.
引用
收藏
页码:1108 / 1111
页数:4
相关论文
共 50 条
  • [1] COLPOSCOPIC EVALUATION OF HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE WOMEN
    MAIMAN, M
    TARRICONE, N
    VIEIRA, J
    SUAREZ, J
    SERUR, E
    BOYCE, JG
    OBSTETRICS AND GYNECOLOGY, 1991, 78 (01): : 84 - 88
  • [2] HUMAN PAPILLOMAVIRUS INFECTION IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE WOMEN
    SUN, XW
    ELLERBROCK, TV
    LUNGU, O
    CHIASSON, MA
    BUSH, TJ
    WRIGHT, TC
    OBSTETRICS AND GYNECOLOGY, 1995, 85 (05): : 680 - 686
  • [3] Adequacy of screening cervical cytology among human immunodeficiency virus-seropositive women
    Spinillo, A
    Capuzzo, E
    Tenti, P
    De Santolo, A
    Piazzi, G
    Iasci, A
    GYNECOLOGIC ONCOLOGY, 1998, 69 (02) : 109 - 113
  • [4] RECURRENT CERVICAL INTRAEPITHELIAL NEOPLASIA IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE WOMEN
    MAIMAN, M
    FRUCHTER, RG
    SERUR, E
    LEVINE, PA
    ARRASTIA, CD
    SEDLIS, A
    OBSTETRICS AND GYNECOLOGY, 1993, 82 (02): : 170 - 174
  • [5] Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women
    Uvin, SC
    Caliendo, AM
    OBSTETRICS AND GYNECOLOGY, 1997, 90 (05): : 739 - 743
  • [6] Squamous intraepithelial cervical lesions in human immunodeficiency virus-seropositive women
    Sopracordevole, F
    Campagnutta, E
    Parin, A
    Vaccher, E
    Volpe, R
    Scarabelli, C
    JOURNAL OF REPRODUCTIVE MEDICINE, 1996, 41 (08) : 586 - 590
  • [7] Perioperative morbidity and mortality among human immunodeficiency virus-infected women undergoing cesarean delivery
    Louis, Judette
    Landon, Mark B.
    Gersnoviez, Rebecca J.
    Leveno, Kenneth J.
    Spong, Catherine Y.
    Rouse, Dwight J.
    Moawad, Atef H.
    Varner, Michael W.
    Caritis, Steve N.
    Harper, Margaret
    Wapner, Ronald J.
    Miodovnik, Menachem
    Carpenter, Marshall
    Peaceman, Alan M.
    O'Sullivan, Mary J.
    Sibai, Baha M.
    Langer, Oded
    Thorp, John M.
    Ramin, Susan M.
    Mercer, Brian M.
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (02): : 385 - 390
  • [8] Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women
    Strickler, HD
    Palefsky, JM
    Shah, KV
    Anastos, K
    Klein, RS
    Minkoff, H
    Duerr, A
    Massad, LS
    Celentano, DD
    Hall, C
    Fazzari, M
    Cu-Uvin, S
    Bacon, M
    Schuman, P
    Levine, AM
    Durante, AJ
    Gange, S
    Melnick, S
    Burk, RD
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (14): : 1062 - 1071
  • [9] Perianal ulcers in a human immunodeficiency virus-seropositive man
    Corti, Marcelo
    De Carolis, Luis
    Messina, Fernando
    REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2016, 49 (01) : 146 - 146
  • [10] ANAL HUMAN PAPILLOMAVIRUS INFECTION AMONG HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE AND VIRUS-SERONEGATIVE MEN
    KIVIAT, N
    ROMPALO, A
    BOWDEN, R
    GALLOWAY, D
    HOLMES, KK
    COREY, L
    ROBERTS, PL
    STAMM, WE
    JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (02): : 358 - 361